Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Study Evaluating the Contribution of Rheopheresis in the Treatment of Uremic Calciphylaxis

NCT05633121 is registered in ClinicalTrials.gov with Association ECHO as lead sponsor.

NCT NCT05633121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05633121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Study Evaluating the Contribution of Rheopheresis in the Treatment of Uremic Calciphylaxis
Lead sponsor
Association ECHO
Phase
Observational
Overall status
Completed
Start date
May 20, 2021
Completion date
September 30, 2023
Enrollment
55 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

calcifying uremic arteriolopathy, rheopheresis, uremic calciphylaxis